# Regadenoson

NDC: 76329-3321
Generic name: Regadenoson
Labeler / Manufacturer: International Medication Systems, Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20230420

FDA application: ANDA214252

## Active ingredients

- REGADENOSON ANHYDROUS: .08 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76329-3321"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76329-3321
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=288c76cc-ff3e-47ea-ae02-be566bd3e093